Confluence Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
CPBTD
VCM
FFA
GI
MPWT
CA
Confluence Investment Management's HAE Position: Q3 2026 in Review
Confluence Investment Management reduced its Haemonetics (HAE) stake by 23% in Q3 2026, selling an estimated $418K and leaving 14,963 shares worth $1.58M. The position accounts for 0.03% of the portfolio, ranked #184.
Confluence Investment Management first reported a position in HAE in Q2 2013 and has held it in 24 quarters since. The position peaked at $2.97M in Q2 2025. 7 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Confluence Investment Management held 14,963 shares of Haemonetics worth $1.58M as of Q3 2026.
- Confluence Investment Management sold 4,492 Haemonetics shares in Q3 2026, an estimated $418K.
- Haemonetics made up 0.03% of Confluence Investment Management's portfolio in Q3 2026, its #184 holding.
- Confluence Investment Management first reported a position in Haemonetics in Q2 2013 and has held it in 24 quarters since.
- Confluence Investment Management's Haemonetics position peaked at $2.97M in Q2 2025.
- 7 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Confluence Investment Management's 13F filing for Q3 2026, filed 1 Oct 2026.